The UK is moving toward a major update of how artificial intelligence is regulated in healthcare, with recommendations calling for continuous monitoring, staged approvals, stronger enforcement and greater transparency for patients. The National Commission into the Regulation of AI in Healthcare published its recommendations after an extensive programme of research and engagement. The proposed UK’s new AI healthcare regulations would shift oversight away from one-time approval and toward monitoring AI throughout its working life.
The recommendations are not yet new NHS AI healthcare laws. The government and the Medicines and Healthcare products Regulatory Agency (MHRA) will now assess the implementation of the proposals for the UK’s New AI Healthcare Regulations.
Why Are The UK’s New AI Healthcare Regulations Needed?
AI systems differ from many traditional medical devices because they can change after deployment, perform differently in different settings and respond to new data. The Commission said a framework that relies too heavily on one-off checks before deployment would not provide enough protection.
Instead, the proposed UK regulations on AI in healthcare would follow an AI product throughout its lifecycle, from development and deployment to updates, monitoring and real-world use.
The Commission described the future framework as needing to be “safe, fast and trusted” while balancing patient safety with responsible innovation.
The report published by the National Commission into the Regulation of AI in Healthcare also reflects extensive public and professional engagement. More than 12,000 people, including patients, clinicians, healthcare leaders and technology developers, contributed to the work.
What Will Change Amid the UK’s New AI Healthcare Regulations?
- Continuous Monitoring Under NHS AI Regulations
One of the biggest proposed changes in the NHS AI regulations is continuous, real-world monitoring of AI-enabled medical devices.
Under the proposed UK healthcare AI framework, regulators would monitor how systems perform after they enter healthcare settings rather than relying mainly on pre-market evidence. Monitoring could identify performance deterioration, emerging risks and other safety concerns.
The Commission recommends more regular performance reporting and processes for escalating problems when an AI system’s performance declines, even if no reportable incident has occurred.
This approach is particularly important because AI systems can evolve over time. It could also give healthcare professionals greater confidence that AI tools remain safe after deployment.
- Staged Approvals for New AI Models
The proposed framework would also introduce staged authorisations for some AI-enabled medical devices.
Under this approach, a technology could initially operate within a tightly controlled scope, with additional evidence and monitoring required before its use expands. The aim is to allow promising technologies to reach patients sooner while maintaining safeguards.
The Commission says staged authorisation should include clear risk controls, transparent communication and a defined route toward full market authorisation.
- More Transparency for Patients
The recommendations for the UK’s new AI healthcare regulations also place greater emphasis on helping patients understand how AI is used in their care.
The future system could provide easily searchable information about specific AI-enabled medical devices and related safety incidents. Patients could also receive clearer information about when and how AI contributes to their care.
This focus responds to concerns about trust and accountability as AI becomes more common across the NHS.
- Stronger MHRA Enforcement Powers
The proposed new NHS AI healthcare law, if ultimately developed from these recommendations, could also give the MHRA stronger enforcement mechanisms.
The Commission recommends enhanced powers that would allow the regulator to respond more quickly when AI-enabled medical devices fail to meet expected standards.
What Could the Law Changes Mean for NHS Staff and Patients?
For healthcare professionals, the proposed NHS AI regulations would bring greater emphasis on human oversight, training, governance and clear responsibilities. The Commission states that AI should support healthcare professionals rather than replace clinical judgment.
For patients, the proposals could mean greater transparency, clearer safety information and stronger oversight of AI technologies used in healthcare.
For developers and health technology companies, the framework could create clearer expectations around evidence, monitoring, risk management and accountability throughout a product’s lifecycle.
What’s Next For UK Regulations on AI in Healthcare?
The UK’s new AI healthcare regulations remain a developing policy framework rather than a completed set of new laws. The Commission has submitted its recommendations, and a cross-government response will follow.
The direction is clear: the UK wants healthcare AI regulation to become more adaptive, evidence-based and focused on real-world safety. As MHRA Chief Executive Lawrence Tallon said, the opportunity to use AI to improve care will depend on a regulatory framework that can “accelerate safe adoption, protect patients and command public and professional confidence.”
If implemented, the proposed framework could shape how AI is developed, approved, monitored and used across UK healthcare while attempting to balance faster innovation with patient safety and public trust.
